Search Results - "Sakagami, Yasuko"
-
1
Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)
Published in Journal of Virology (01-01-2008)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
2
SC29EK, a Peptide Fusion Inhibitor with Enhanced α-Helicity, Inhibits Replication of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide
Published in Antimicrobial Agents and Chemotherapy (01-03-2009)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
3
Amino Acid Mutation N348I in the Connection Subdomain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Multiclass Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors
Published in Journal of Virology (01-04-2008)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
4
Resistance Profiles of Novel Electrostatically Constrained HIV-1 Fusion Inhibitors
Published in The Journal of biological chemistry (10-12-2010)“…Human immunodeficiency virus (HIV) gp41 plays a key role in viral fusion; the N- and C-terminal heptad repeats (N-HR and C-HR) of gp41 form a stable 6-helical…”
Get full text
Journal Article -
5
Design of Peptide-based Inhibitors for Human Immunodeficiency Virus Type 1 Strains Resistant to T-20
Published in The Journal of biological chemistry (20-02-2009)“…Enfuvirtide (T-20) is a fusion inhibitor that suppresses replication of human immunodeficiency virus (HIV) variants with multi-drug resistance to reverse…”
Get full text
Journal Article -
6
K70Q adds high-level tenofovir resistance to "Q151M complex" HIV reverse transcriptase through the enhanced discrimination mechanism
Published in PloS one (13-01-2011)“…HIV-1 carrying the "Q151M complex" reverse transcriptase (RT) mutations (A62V/V75I/F77L/F116Y/Q151M, or Q151Mc) is resistant to many FDA-approved nucleoside RT…”
Get full text
Journal Article -
7
HIV-1 Resistance Mechanism to an Electrostatically Constrained Peptide Fusion Inhibitor That Is Active against T-20-Resistant Strains
Published in Antimicrobial Agents and Chemotherapy (01-08-2013)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
8
Mechanism of resistance to S138A substituted enfuvirtide and its application to peptide design
Published in The international journal of biochemistry & cell biology (01-04-2013)“…► T-20S138A, a resistance mutation introduced peptide, blocks T20-resistant HIV-1. ► To determine how HIV-1 escapes, we induced T-20S138A-resistant HIV-1 in…”
Get full text
Journal Article -
9
Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naïve patients
Published in Antiviral research (01-06-2009)“…Some mutations in the connection subdomain of the polymerase domain and in the RNase H domain of HIV-1 reverse transcriptase (RT) have been shown to contribute…”
Get full text
Journal Article -
10
Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat
Published in Antiviral research (01-08-2010)“…A transmembrane glycoprotein of HIV-1, gp41, plays a central role in membrane fusion of HIV-1 and host cells. Peptides derived from the amino- and…”
Get full text
Journal Article -
11
Dual-Reporter Phenotypic Assay for Human Immunodeficiency Viruses
Published in Journal of Clinical Microbiology (01-02-2008)“…We have established a novel human immunodeficiency virus (HIV) tandem-reporter assay using HIV receptor-transduced NP-2 cells with long terminal…”
Get full text
Journal Article -
12
2′-Deoxy-4′- C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants
Published in The international journal of biochemistry & cell biology (2008)“…One of the formidable challenges in therapy of infections by human immunodeficiency virus (HIV) is the emergence of drug-resistant variants that attenuate the…”
Get full text
Journal Article -
13
Design of a Novel HIV-1 Fusion Inhibitor That Displays a Minimal Interface for Binding Affinity
Published in Journal of medicinal chemistry (14-02-2008)“…Reported herein are the design, biological activities, and biophysical properties of a novel HIV-1 membrane fusion inhibitor. α-Helix-inducible X-EE-XX-KK…”
Get full text
Journal Article -
14
Electrostatically constrained α-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide
Published in The international journal of biochemistry & cell biology (01-04-2009)“…α-Helical peptides, such as T-20 (enfuvirtide) and C34, derived from the gp41 carboxyl-terminal heptad repeat (C-HR) of HIV-1, inhibit membrane fusion of HIV-1…”
Get full text
Journal Article -
15
Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4
Published in The international journal of biochemistry & cell biology (01-09-2010)“…Rev, a viral regulatory protein of HIV-1, binds through its arginine-rich domain to the Rev-responsive element (RRE), a secondary structure in transcribed…”
Get full text
Journal Article -
16
Synonymous mutations in stem-loop III of Rev responsive elements enhance HIV-1 replication impaired by primary mutations for resistance to enfuvirtide
Published in Antiviral research (01-04-2009)“…Primary mutations in HIV-1 that are directly involved in the resistance to enfuvirtide have been well documented. However, secondary mutations that are…”
Get full text
Journal Article -
17
SC29EK, a Peptide Fusion Inhibitor with Enhanced -Helicity, Inhibits Replication of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide
Published in Antimicrobial agents and chemotherapy (01-03-2009)“…Peptides derived from the -helical domains of human immunodeficiency virus (HIV) type 1 (HIV-1) gp41 inhibit HIV-1 fusion to the cell membrane. Enfuvirtide…”
Get full text
Journal Article -
18
Design of Peptide-based Inhibitors for Human Immunodeficiency Virus Type 1 Strains Resistant to T-20S
Published in The Journal of biological chemistry (20-02-2009)“…Enfuvirtide (T-20) is a fusion inhibitor that suppresses replication of human immunodeficiency virus (HIV) variants with multi-drug resistance to reverse…”
Get full text
Journal Article -
19
-
20
Clinical relevance of substitutions in the connection subdomain and RNase H domains of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naïve patients
Published in Antiviral research (21-02-2009)“…Some mutations in the connection subdomain of the polymerase domain and in the RNase H domain of HIV-1 reverse transcriptase (RT) have been shown to contribute…”
Get full text
Journal Article